Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study
Author:
Affiliation:
1. The Hospital for Sick Children and University of Toronto Toronto Ontario Canada
2. Duke University Durham North Carolina
3. University of Alabama at Birmingham
4. University of Minnesota Masonic Children's Hospital Minneapolis
Publisher
Wiley
Subject
Rheumatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24859
Reference34 articles.
1. Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
2. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis
3. Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
4. Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
5. A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment;Pediatric Rheumatology;2023-12-20
2. Comparison of biologic monotherapy versus biologic and disease-modifying anti-rheumatic drug combination in the treatment of non-systemic juvenile idiopathic arthritis;Turkish Journal of Pediatric Disease;2023-09-18
3. OP0300 INCREASING THE ETANERCEPT DOSE IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS: DOES IT HELP REACHING THE TREATMENT TARGET? A POST-HOC ANALYSIS OF THE BEST4KIDS RANDOMISED CLINICAL TRIAL;Scientific Abstracts;2023-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3